Thank you, Mr. Chair.
Thank you to the witnesses for being with us.
Ms. Walker, in your opening statement, you said that pharmacare should be about more than just the cost of drugs. It should also be about the care or counselling that goes along with the treatment.
Can you talk more about that? What exactly do you mean?